Markets:

Overview

News

Currencies

International

Treasuries

Mainz Biomed N.V. - Ordinary Shares (NQ:MYNZ)

0.6659 -0.1341 (-16.76%)

Streaming Delayed Price Updated: 10:29 AM EST, Feb 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Mainz Biomed N.V. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >

2 Small-Cap Biotechs That Could Reward Patient Investors ↗

December 12, 2025

Via MarketBeat

Get insights into the top gainers and losers of Wednesday's pre-market session. ↗

December 03, 2025

Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.

Via Chartmill

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

November 13, 2025

Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 13, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 13, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 01, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 16, 2025

Via Benzinga

These stocks are moving in today's pre-market session ↗

May 19, 2025

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

May 19, 2025

Via Benzinga

Why Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗

May 19, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 08, 2025

Via Benzinga

Mainz Biomed Vs. Aurinia Pharma: Retail Traders Weigh In On The Better Biotech Bet ↗

March 07, 2025

Over the past three months, Mainz has seen a staggering 2,500% increase in message volume on Stocktwits, while Aurinia’s engagement has grown just 23%.

Via Stocktwits

This Analog Devices Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday ↗

February 14, 2025

Via Benzinga

Which stocks are moving after the closing bell on Friday? ↗

January 31, 2025

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Via Chartmill

Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S.

December 20, 2024

Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S.

Via News Direct

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 19, 2024

Via Benzinga

Mainz Biomed Announces Reverse Stock Split Soon After Collaborating With MedTech Giant Thermo Fisher Scientific ↗

December 03, 2024

Mainz Biomed partners with Thermo Fisher to develop advanced colorectal cancer screening tools while enhancing ColoAlert for faster, accurate results.

Via Benzinga

Mainz Biomed Inks Major Deal To Develop A Next-Generation Cancer Test

November 22, 2024

Mainz Biomed Inks Major Deal To Develop A Next-Generation Cancer Test

Via News Direct

The Oncology Bet Is Already Paying Off For Pfizer ↗

November 13, 2024

With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story. Earlier in October, Pfizer Inc (NYSE: PFE) reported its third quarter revenue grew 14%...

Via Benzinga

Healthcare Giant Thermo Fisher Scientific Inc. (NYSE: TMO) Inks Deal With Mainz Biomed (NASDAQ: MYNZ) To Develop And Commercialize Next Gen Colorectal Cancer Screening

November 13, 2024

Healthcare Giant Thermo Fisher Scientific Inc. (NYSE: TMO) Inks Deal With Mainz Biomed (NASDAQ: MYNZ) To Develop And Commercialize Next Gen Colorectal Cancer Screening

Via News Direct

What Mainz Biomed (NASDAQ: MYNZ) Has Been Up To Recently And Why Frankie Muniz Is A Backer

November 12, 2024

What Mainz Biomed (NASDAQ: MYNZ) Has Been Up To Recently And Why Frankie Muniz Is A Backer

Via News Direct

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 15, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 15, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 14, 2024

Via Benzinga

Personalized Treatment And Immunotherapy Are Pharma's Newest Weapons Against Cancer ↗

October 10, 2024

On Sunday, The Guardian issued an article that spoke of a UK study that could transform how cancer is treated. The large-scale clinical project assessed how personalized cancer therapies could...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 07, 2024

Via Benzinga

Former Senior Advisor To Obama Joins Forces With Innovative Biotech To Catch Cancer Early

October 07, 2024

Former Senior Advisor To Obama Joins Forces With Innovative Biotech To Catch Cancer Early

Via News Direct

The Covid Era Tech Promises To Reinvent Cancer Treatment ↗

October 01, 2024

Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning to oncology for its next growth story.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 27, 2024

Via Benzinga

Pfizer Advances On Its Cancer Journey ↗

September 20, 2024

On Saturday, Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer cachexia during the European Society for Medical Oncology 2024...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.